Dasatinib + dexamethasone

Intervention

1 paper studies it5 more mention it1 finding

PubChemPubChemChEBIChEBI

  • 1 lab in 1 country
  • Funder: Wilhelm Sander-Stiftung
  • Cells1

Outcomes

1

BCAR1

downin human cells1

1 study
  1. Dasatinib + dexamethasone decreases BCAR1 in human cells.

    “Dasatinib and Dexamethasone combination treatment showed strong synergistic effects on Src and p130Cas phosphorylation and led to reduced p130Cas expression.”

    Cellscombination treatment in TSCC lines

    The Src family kinase inhibitor drug Dasatinib and glucocorticoids display synergistic activity against tongue squamous cell carcinoma and reduce MET kinase activity

    Cell communication and signaling : CCSJun 19, 2025

More on BCAR1

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 paper in 12 months